News

May 25, 2021- PRESS RELEASE

Emboline Raises over $55 Million in Series D Funding for Pivotal FDA Clinical Study and Market Launch of the Emboliner® Embolic Protection Catheter to Minimize Stroke Risk from TAVR

January 5, 2021- PRESS RELEASE

Emboline™ Raises Over $10 Million in Series C Funding to Fund Further Development of the Emboliner™ Embolic Protection Catheter to Minimize Stroke Risk From TAVR

October 14, 2020- ABSTRACT

Clinical Performance of a Total Embolic Protection Device: Results of the Emboliner SafePass 2 Study. Sanjeevan Pasupati MD, Waikato Hospital, Hamilton, New Zealand. TCT 2020.

October 14, 2020- ABSTRACT

Capture and Analysis of Debris Generated During TAVR — Can it Inform our Treatment Decisions and Prognoses? Sanjeevan Pasupati MD, Waikato Hospital, Hamilton, New Zealand. TCT 2020.

January 15, 2020- PRESS RELEASE

Emboline Completes Enrollment in SafePass 2 Clinical Study of Emboliner Embolic Protection Catheter

June 5, 2018- PRESS RELEASE

Emboline, Inc. Completes Initial Human Clinical Cases with the Emboliner Embolic Protection Catheter

April 19, 2018- PRESS RELEASE

Emboline, Inc. Completes Funding of Over $10 million

October 28, 2016- PRESS RELEASE

Emboline’s “Enabling TAVI” Aortic Embolic Protection Technology Selected for Presentation at TCT 2016

September 15, 2014- PRESENTATION

The Emboline Aortic Embolic Protection Technology. Scott Russell, President and CEO, Emboline. TCT 2014.

December 2, 2013- PRESENTATION

The Emboline Aortic Embolic Protection Systems. Amir Belson, MD, Founder and CTO, Emboline. ICI 2013.

Emboline, Inc.
Santa Cruz, CA USA
Tel: +1 (831) 900-5020 • Fax: +1 (831) 900-5019
info@emboline.com